rc 3095 has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battastini, AM; Braganhol, E; Brunetto, AL; Cechim, G; de Castro, CG; de Oliveira, MS; Lenz, G; Meurer, L; Roesler, R; Santos, DG; Schwarstmann, G; Schwartsmann, G | 1 |
| Groot, K; Halmos, G; Pinski, J; Schally, AV; Szepeshazi, K | 1 |
| Armatis, P; Groot, K; Kiaris, H; Schally, AV; Sun, B | 1 |
3 other study(ies) available for rc 3095 and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bombesin; Brain Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Dacarbazine; Exploratory Behavior; Flow Cytometry; Glioblastoma; Male; Peptide Fragments; Rats; Rats, Wistar; Receptors, Bombesin; Temozolomide | 2009 |
Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Topics: Amino Acid Sequence; Animals; Bombesin; Cell Division; Drug Screening Assays, Antitumor; ErbB Receptors; Gastrins; Glioblastoma; Male; Mice; Mice, Nude; Molecular Sequence Data; Peptide Fragments; Receptors, Bombesin; Somatostatin; Tumor Cells, Cultured | 1994 |
Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
Topics: Animals; Base Sequence; Bombesin; Brain Neoplasms; Cell Division; DNA Primers; Gastrin-Releasing Peptide; Glioblastoma; Humans; Mice; Mice, Nude; Peptide Fragments; Proto-Oncogene Proteins c-fos; RNA, Messenger | 1999 |